Restricted Stock, Restricted Stock Units, and Stock Options |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Share-Based Payment Arrangement [Abstract] | |
| Restricted Stock, Restricted Stock Units, and Stock Options | Note 2. Restricted Stock, Restricted Stock Units, and Stock Options As of March 31, 2026, the Company has three equity incentive plans: the AMERISAFE Non-Employee Director Restricted Stock Plan (the Restricted Stock Plan), the AMERISAFE 2012 Equity and Incentive Compensation Plan (the 2012 Incentive Plan) and the 2022 Equity and Incentive Compensation Plan (the 2022 Incentive Plan). In connection with the approval of the 2022 Incentive Plan by the Company’s shareholders at the annual meeting of shareholders in June 2022, no further grants will be made under the 2012 Incentive Plan. All grants made under the 2012 Incentive Plan will continue in effect, subject to the terms and conditions of the 2012 Incentive Plan. See Note 12 to the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 for additional information regarding the Company’s incentive plans. During the three months ended March 31, 2026, the Company issued 24,619 shares of common stock to executive officers pursuant to vested performance awards and 4,230 shares of common stock to executive officers upon the vesting of restricted stock units (RSUs). The market value of these shares totaled $0.9 million. During the three months ended March 31, 2025, no shares of common stock were issued. The Company had no stock options outstanding as of March 31, 2026. The Company recognized share-based compensation expense of $0.6 million in the three months ended March 31, 2026 and $1.1 million in the same period in 2025. |